1 NADPH oxidases as therapeutic targets in chronic myeloid leukemia

NADPH oxidases as therapeutic targets in chronic myeloid leukemia Authors: Beatriz Sánchez-Sánchez, Sara Gutiérrez-Herrero, Guillermo López-Ruano, Rodrigo Prieto-Bermejo, Marta Romo-González, Marcial Llanillo, Atanasio Pandiella, Carmen Guerrero, Jesús F. San Miguel , Fermín Sánchez-Guijo, Consuelo del Cañizo, and Angel Hernández-Hernández Affiliations: Department of Biochemistry and Molecular Biology, University of Salamanca, Salamanca, Spain Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain. CIC, Centro de Investigación del Cáncer, CSIC, Salamanca. Spain Hospital Universitario de Salamanca, Salamanca, Spain. Corresponding author: Dr. Angel Hernández-Hernández Edificio Departamental, Lab. 122 Plaza Doctores de la Reina s/n 37007 Salamanca. Spain Tel: +34923 294 781 Fax: +34-923 294 579 E-mail: angelhh@usal.es Running Title: NADPH oxidase inhibitors and BCR-ABL inhibitors synergize